共 288 条
[1]
Elliott PM(2014)2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur Heart J 35 2733-2779
[2]
Anastasakis A(2011)2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and
[3]
Borger MA(2018)Hypertrophic cardiomyopathy: clinical update JACC: Heart Failure 6 364-375
[4]
Borggrefe M(2020)Hypertrophic cardiomyopathy IJC Heart Vasc 27 100503-1986
[5]
Cecchi F(2019)Moving beyond the sarcomere to explain heterogeneity in hypertrophic cardiomyopathy: JACC Review Topic of the Week J Am Coll Cardiol 73 1978-354
[6]
Charron P(2016)Hypertrophic Cardiomyopathy from A to Z: Genetics, pathophysiology, imaging, and management. radiographics Radiol Soc N Am 36 335-872
[7]
Gersh BJ(2016)The remarkable 50 years of imaging in HCM and how it has changed diagnosis and management: from M-mode echocardiography to CMR JACC Cardiovasc Imaging 9 858-2345
[8]
Maron BJ(2019)Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry J Am Coll Cardiol 74 2333-773
[9]
Bonow RO(2017)Hypertrophic Cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management J Am Coll Cardiol 69 761-1252
[10]
Dearani JA(2019)Structural abnormalities in hypertrophic cardiomyopathy beyond left ventricular hypertrophy by multimodality imaging evaluation Echocardiography. 36 1241-1679